ACCENTIA BIOPHARMACEUTICALS INC (ABPI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 49 transactions totaling $8.2M, demonstrating a bullish sentiment with $8.0M in net insider flow. The most recent transaction on Nov 8, 2013 involved a transaction of 1,375,000 shares valued at $0.
No significant insider buying has been recorded for ABPI in the recent period.
No significant insider selling has been recorded for ABPI in the recent period.
Based on recent SEC filings, insider sentiment for ABPI is bullish with an Insider Alignment Score of 99/100 and a net flow of $8.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ACCENTIA BIOPHARMACEUTICALS INC (ABPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading ABPI stock, having executed 49 transactions in the past 90 days. The most active insider is Francis E. Odonnell Jr (Executive), who has made 20 transactions totaling $8.3M.
Get notified when executives and directors at ABPI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 8, 2013 | E. Odonnell Francis Jr | Executive | Other | 1,375,000 | $N/A | $0 | |
| Oct 24, 2012 | E. Odonnell Francis Jr | Executive | Other | 500,000 | $N/A | $0 | |
| Apr 12, 2012 | E. Odonnell Francis Jr | Executive | Other | 100,000 | $0.37 | $37.0K | |
| Feb 17, 2012 | E. Odonnell Francis Jr | Executive | Other | 125,000 | $N/A | $0 | |
| Feb 17, 2012 | E. Odonnell Francis Jr | Executive | Other | 375,000 | $N/A | $0 | |
| Dec 23, 2011 | E. Odonnell Francis Jr | Executive | Sale | 500,000 | $0.20 | $100.0K | |
| Oct 5, 2011 | E. Odonnell Francis Jr | Executive | Other | 500,000 | $N/A | $0 | |
| Jan 10, 2011 | M. Pearce Alan | Executive | Award | 66,000 | $N/A | $0 | |
| Dec 17, 2010 | M. Pearce Alan | Executive | Other | 206,896 | $N/A | $0 | |
| Nov 24, 2010 | M. Pearce Alan | Executive | Award | 750,000 | $N/A | $0 | |
| Nov 24, 2010 | E. Odonnell Francis Jr | Executive | Purchase | 225,954 | $0.99 | $223.7K | |
| Nov 24, 2010 | E. Odonnell Francis Jr | Executive | Award | 750,000 | $N/A | $0 | |
| Aug 12, 2008 | E. Odonnell Francis Jr | Executive | Purchase | 11,400 | $0.95 | $10.8K | |
| Aug 11, 2008 | E. Odonnell Francis Jr | Executive | Purchase | 13,600 | $0.94 | $12.8K | |
| Aug 8, 2008 | E. Odonnell Francis Jr | Executive | Purchase | 25,000 | $0.94 | $23.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 10 | $8.1M | 96.2% |
Other(J) | 19 | $218.8K | 2.6% |
Sale(S) | 1 | $100.0K | 1.2% |
Award(A) | 3 | $0 | 0.0% |
Gift(G) | 16 | $0 | 0.0% |
Insiders at ACCENTIA BIOPHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 8 insiders making 49 transactions totaling $8.1M in purchases versus $100.0K in sales, the net buying activity of $8.0M signals strong executive confidence. Francis E. Odonnell Jr (Executive) leads the buying activity with $8.3M in transactions across all time.